Karabicici, M. Et Al. 2021. Doxorubicin-induced senescence promotes stemness and tumorigenicity in EpCAM-/CD133-nonstem cell population in hepatocellular carcinoma cell line, HuH-7. MOLECULAR ONCOLOGY , vol.15, no.8 , 2185-2202.

Karabicici, M., Alptekin, S., Firtina Karagonlar, Z., & ERDAL BAĞRIYANIK, Ş. E., (2021). Doxorubicin-induced senescence promotes stemness and tumorigenicity in EpCAM-/CD133-nonstem cell population in hepatocellular carcinoma cell line, HuH-7. MOLECULAR ONCOLOGY , vol.15, no.8, 2185-2202.

Karabicici, Mustafa Et Al. "Doxorubicin-induced senescence promotes stemness and tumorigenicity in EpCAM-/CD133-nonstem cell population in hepatocellular carcinoma cell line, HuH-7," MOLECULAR ONCOLOGY , vol.15, no.8, 2185-2202, 2021

Karabicici, Mustafa Et Al. "Doxorubicin-induced senescence promotes stemness and tumorigenicity in EpCAM-/CD133-nonstem cell population in hepatocellular carcinoma cell line, HuH-7." MOLECULAR ONCOLOGY , vol.15, no.8, pp.2185-2202, 2021

Karabicici, M. Et Al. (2021) . "Doxorubicin-induced senescence promotes stemness and tumorigenicity in EpCAM-/CD133-nonstem cell population in hepatocellular carcinoma cell line, HuH-7." MOLECULAR ONCOLOGY , vol.15, no.8, pp.2185-2202.

@article{article, author={Mustafa Karabicici Et Al. }, title={Doxorubicin-induced senescence promotes stemness and tumorigenicity in EpCAM-/CD133-nonstem cell population in hepatocellular carcinoma cell line, HuH-7}, journal={MOLECULAR ONCOLOGY}, year=2021, pages={2185-2202} }